People · Operator
Named in public records as an officer, director or promoter · active 2009–2025 · Other, Other Technology, Business Services, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Cannapharmarx, Inc. | — | Other | Series B | $38.8M | $2.8M | 2014 |
| OurStage, Inc | — | Other Technology | Series A | $32.6M | $10.9M | 2009 |
| Fixe, Inc. | — | Business Services | Seed | $2.4M | $2.8M | 2023 |
| FanTree, Inc. | — | Other Technology | Pre-Seed | $629K | $7.2M | 2013 |
| CannaPharmaRX, Inc. | — | Pharmaceuticals | Pre-Seed | $500K | $23.7M | 2014 |
| Advanced Movement Insights, Inc. | — | Other | Pre-Seed | $200K | $455K | 2025 |
Gary Cohen at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Gary Cohen on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| GARY HERICK | 2 | 2 |
| GERRY CROCKER | 2 | 2 |
| DAVID MOORE | 1 | 13 |
| Tim Pollack | 1 | 4 |
| Wendy DiCicco | 1 | 4 |
| William Turner | 1 | 4 |
| Steve Pogorzelski | 1 | 4 |
| JAMES SMEEDING | 1 | 3 |
| Matthew Nicosia | 1 | 3 |
| John Roth | 1 | 3 |
| Paula Schmitz | 1 | 3 |
| John Costello | 1 | 2 |
| CHRISTOPHER SCHNITTKER | 1 | 2 |
| Richard Slocum | 1 | 2 |
| John Partilla | 1 | 2 |
| STEVEN RULE | 1 | 1 |
| Ray Volpe | 1 | 1 |
| DAVID POHL | 1 | 1 |
| GERALD CROCKER | 1 | 1 |
| ROBERT LIESS | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.